SAREPTA THERAPEUTICS, INC. Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31)
SAREPTA THERAPEUTICS, INC. (SRPT) reported Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) of 16.70% for the 1-month period ending 2012-07-31, per its 10-Q filed 2013-05-09.
Discontinued › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio · last filed 2013-05-09
- 2012-07-31: Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) 1 month 16.70%.
pure
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) 1 month |
|---|---|
| 2012-07-31 | 16.70% 10-Q · filed 2013-05-09 |
shares
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) 1 month |
|---|---|
| 2012-07-31 | 0.17 shares 10-Q · filed 2012-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |